Healthcare Analytics, Population Health Management, Healthcare Big Data

Personalized Medicine

Genomics, Clinical Decision Support Combo Cuts ED Visits by 42%

February 8, 2017 - Providers who combined genetic testing with a clinical decision support tool to treat home health patients using multiple medications were able to reduce hospital readmissions by 52 percent and cut ED visits by 42 percent, according to a study published in PLOS ONE. The study, conducted by researchers from Harding University and Unity Health-White County Medical Center, also found that conducting...


More Articles

Genomics, Clinical Decision Support Combo Cuts ED Visits by 42%

by Jennifer Bresnick

Providers who combined genetic testing with a clinical decision support tool to treat home health patients using multiple medications were able to reduce hospital readmissions by 52 percent and cut ED visits by 42 percent, according to a study...

NIH Awards $21M to Precision Medicine Epilepsy Collaboration

by Jennifer Bresnick

An international academic research consortium will use precision medicine strategies and a new $21 million grant from the National Institutes of Health to further research into the development and treatment of epilepsy. The collaboration, spearheaded...

Precision Medicine Benefits Pediatric Cancer Care, Study Says

by Thomas Beaton

Investigators at the Dana-Farber/Boston Children's Cancer and Blood Disorders Center found that precision medicine can be used to diagnose genetic abnormalities and properly treat patients with pediatric brain cancers. By testing tumor samples,...

Northwell Health Launches Precision Medicine, Cancer Biobank

by Thomas Beaton

Northwell Health and Indivumed are creating a new patient biobank to help expand opportunities for cancer research and the development of precision medicine therapies. In the three-year agreement announced in a press release this week, Northwell...

Cancer Research Orgs Release Big Data for Precision Medicine

by Jennifer Bresnick

The American Association for Cancer Research (AACR) is releasing more than 19,000 de-identified genomic records to further the international research community’s explorations into precision medicine.  The big data dump, which includes...

Precision Medicine, Big Data Partnerships Will Enhance Treatment

by Jennifer Bresnick

The calendar year may be coming to its end, but the nation’s work on precision medicine is just getting started.  Spurred on by the continuing development of big data analytics techniques and pepped up by the landslide passage of the...

Penn Precision Medicine Accelerator Doles Out $525K in Grants

by Jennifer Bresnick

The Penn Center for Precision Medicine (PCMP) Accelerator Fund has divided $525,000 between eight promising personalized medicine projects addressing topics such as neurodegenerative diseases, infection control, cancer, and genetic variants....

FDA Eager for Precision Medicine Under 21st Century Cures Act

by Jennifer Bresnick

The FDA is ready and willing to get started on the precision medicine and drug innovation opportunities created by the 21st Century Cures Act, FDA Commissioner Robert M. Califf, MD, said in a blog post. The legislation, signed into law by President...

Two Cancer Research Centers Form Personalized Medicine Alliance

by Jennifer Bresnick

The Translational Genomics Research Institute (TGen) and the independent City of Hope cancer and diabetes center have announced a new research alliance aimed at accelerating the development of personalized medicine and precision therapies for...

21st Century Cures Act for Precision Medicine Set for House Vote

by Jennifer Bresnick

Lawmakers anticipating a tough landscape for innovation funding under a new Republican administration are doing their best to push a revamped version of the 21st Century Cures Act through the current Congress, and will bring the $6.3 billion...

Clinical Analytics Studies, Partnerships Target Personalized Care

by Jennifer Bresnick

Personalization isn’t just for online advertisements and shopping suggestions.  It is becoming a primary driver of healthcare innovations, too.  From tailored therapies based on precision medicine techniques to individualized...

Big Data Interoperability a Must for Precision Medicine Progress

by Jennifer Bresnick

The United States healthcare system still has a long way to go before it develops the seamless health data interoperability required to take on the most pressing precision medicine challenges, including finding cures for cancer. According to...

IBM Watson, Mount Sinai Launch New Precision Medicine Projects

by Jennifer Bresnick

Precision medicine partnerships are becoming all the rage as public and private healthcare organizations pool their expertise and resources to overcome the challenges of developing personalized treatments for cancer and other diseases. Some familiar...

CMS: Big Data Access Vital for Precision Medicine, Drug Pricing

by Jennifer Bresnick

Skyrocketing drug prices, insufficient healthcare data transparency, and slugglish precision medicine innovation cycles are placing a significant strain on Medicare patients, many of whom are unable to access cutting-edge treatments and are struggling...

Precision Medicine Partnerships Foster Promises of Breakthroughs

by Jennifer Bresnick

Precision medicine projects, partnerships, and collaborations are continuing to proliferate as providers, research organizations, and vendors look to capitalize on the growing enthusiasm for integrating genomics and personalized insights into...

API-Based Genomics Databank Facilitates Personalized Medicine

by Jennifer Bresnick

Genomic testing is becoming an increasingly common starting place for the development of personalized medicine treatments for patients with a variety of hard-to-treat diseases, especially cancer, but organizations often struggle with interpreting...

FDA, Europe Team up for Precision Medicine, Patient Engagement

by Jennifer Bresnick

The FDA and the European Medicines Agency (EMA) are working together to advance precision medicine treatments for patients with rare diseases, officials announced last week, marking more than a decade of cross-Atlantic collaboration on drug development,...

Precision Medicine Aids 20% Drop in Pediatric Cancer Deaths

by Nathan Boroyan

The pediatric cancer death rate declined by 20 percent between 1999 and 2014, according to new data from the National Center for Health Statistics (NCHS), indicating that precision medicine techniques and an emphasis on personalized care may...

Six Pediatric Hospitals Create Personalized Medicine Coalition

by Jennifer Bresnick

Some of the nation’s most lauded pediatric medical centers are aiming to advance personalized medicine through a new collaborative arrangement funded by philanthropist Denny Sanford. The Sanford Children’s Genomic Medicine Consortium...

Groups Urge $34.1B NIH Budget for Precision Medicine, Research

by Nathan Boroyan

Continued progress with precision medicine, population health, and other critical research activities depends on securing the proposed $34.1 billion budget for the National Institutes of Health, according to more than 200 patient advocacy groups,...

Continue to site...